Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

E.D. Tex.

Centocor, Inc. et al v. Abbott Laboratories, No. 2:07-cv-00139 (E.D. Tex. Nov. 4, 2009)

Denied
Court
U.S. District Court for the Eastern District of Texas, Marshall Division
Case No.
No. 2:07-cv-00139, Dkt. No. 329
Decided
November 4, 2009
Judge
See opinion
Document
Memorandum Opinion and Order
Docket Entry
MEMORANDUM OPINION and ORDER - The Court finds that Abbott has not carried its burden of proving by clear and convincing evidence that the 775 patent is unenforceable or invalid. The Court finds that Abbott has not proven by clear and convi…
Length
28 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

I. INTRODUCTION In this case, plaintiffs Centocor Ort ho Biotech, Inc. (“Cent ocor”) and New York University (“NYU”) (collectively “Plaintiffs”) obt ained a jury verdict of infringement against defendants Abbott Laboratories, Abbott Bioresearch Center, Inc., and Abbott Biotechnology Ltd. (collectively “Abbott”) on June 29, 2009 with respect to claims 2, 3, 14, and 15 of United States Patent No. 7,070,775 (“the ‘775 patent”). ( See Dkt. No. 261, Jury Verdict).